Vogan v. US Oncology, Inc.

301 F. Supp. 2d 1038, 2003 U.S. Dist. LEXIS 25052, 2003 WL 23200384
CourtDistrict Court, W.D. Missouri
DecidedOctober 30, 2003
Docket02-4207-CV-C-NKL
StatusPublished
Cited by2 cases

This text of 301 F. Supp. 2d 1038 (Vogan v. US Oncology, Inc.) is published on Counsel Stack Legal Research, covering District Court, W.D. Missouri primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Vogan v. US Oncology, Inc., 301 F. Supp. 2d 1038, 2003 U.S. Dist. LEXIS 25052, 2003 WL 23200384 (W.D. Mo. 2003).

Opinion

ORDER

LAUGHREY, District Judge.

Pending before the Court is the Defendants’ Motion for Summary Judgment [Doc. #45]. For the reasons stated below, the motion will be denied.

I. Factual Background

Solely for the purpose of the Defendants’ Summary Judgment Motion, the Court views the facts in a light most favorable to the Plaintiff, accepting as true Plaintiff Stacy Vogan’s (“Vogan”) version of the facts when they are disputed.

In this lawsuit, Vogan claims the Defendants terminated her. employment because of her pregnancy in violation of the Pregnancy Discrimination Act (“PDA”) amendments to Title VII, 42 U.S.C. § 2000e, and the Missouri Human Rights Act. 1

Vogan, the plaintiff, was the Clinical Research Coordinator for Missouri Cancer Associates, L.L.C. (“MCA”). Plaintiff contends that she was an employee of U.S. Oncology, Inc. (“USO”), as well. Richard Barker (“Barker”) is employed by USO, but served as the Practice Administrator for MCA, and in that capacity provided some supervision to Vogan. Ken Baker (“Baker”) works for USO as the Regional Director of Research. Robert Davis (“Davis”) is USO’s Regional Director of Human Resources. He administers MCA’s employee benefit plans and employment policies. Dr. Joseph Muscato (“Muscato”) is the physician in charge of the research program at MCA, but he is not an officer or technically an employee of MCA. Vogan worked under Muscato’s direction as well. {See Barker Dep. at pp. 84-85.) Jacqueline Juenger (“Juenger”) is an employee of Boone Hospital and Vo-gan’s former supervisor when Vogan worked at Boone Hospital.

A. Relationship Between MCA and USO

MCA is a Missouri limited liability company. 2 MCA provides oncology medical care to cancer patients.

USO is a corporation that is engaged in providing oncology medical care through *1040 out the United States. One element of USO’s business is managing and providing administrative, training, purchasing, and other services to entities that own and operate already existing oncology medical care facilities.

Since 1995, USO has provided management and administrative services to MCA according to a written service agreement. USO provides all of the non-clinical employees, such as billing clerks, receptionists, and human resources personnel, that work in MCA’s offices. MCA employs all nurses and other clinical staff who provide direct patient care. The non-clinical employees provided by USO handle all administrative tasks of MCA, including: employee payroll services; employee benefits administration; drafting and publishing of employment policies, including the written leave of absence policy at issue in this case; employee benefits; answering employee questions about payroll or policies; monitoring the day-to-day business needs for MCA and the revenues and expenses of MCA; and managing MCA’s central business office.

USO also handles employment issues involving requests for leaves of absence, hiring, termination, evaluation, transfers, pay changes, and facilitating communications between MCA departments. (Def. Ex. D (Barker Aff.) ¶ 3 (“I have been ultimately responsible for making employment decisions such as hiring, terminating, disciplining, and approving requests for leave of absence for non-physician employees of USO and MCA....”).)

B.Hiring Vogan

On August 14, 2001, Vogan was hired to the position of MCA’s Clinical Research Coordinator. Muscato had input into hiring Vogan. Muscato interviewed Vogan and recommended her for the job over another candidate. According to him, his input was important. This is because he is the physician in charge of the research aspect of the practice. Muscato supervised Vogan’s professional activities.

When Vogan first inquired about the position, she asked Muscato who she needed to talk to about the job. Muscato replied that he was in charge of the research and that she would need to talk to him. She met with only Muscato and the person she was replacing before she was hired.

C. Vogan’s Pregnancy

In October 2000, Vogan informed Barker that she was pregnant with twins. She told Barker she might need bed rest at twenty weeks. Barker responded in a supportive manner to Vogan’s announcement:

Q: What was Rik’s reaction when you told him- — or Rik Barker’s reaction when you told him?
A: He took it very well. He wasn’t too upset or worried.
Q: Would you characterize his reaction as supportive?
A: I don’t know that I can.
Yeah, for a supervisor, he was supportive.

(Vogan Dep. at pp. 35-36.)

In late January 2001, at twenty-two weeks into pregnancy, Vogan requested leave from Barker because she was placed on bed rest. She began her leave of absence on February 2, 2001. 3

D. Vogan’s Replacement

Vogan discussed with Barker finding a temporary replacement for her position while she was on bed rest. Vogan posted *1041 the temporary position and interviewed candidates for it. Vogan recommended that her temporary replacement be Lisa Atkins (“Atkins”). Atkins was officially assigned to the Clinical Research Coordinator position in March 2001.

E. Discriminatory Statement

Juenger testified that she heard a statement made by Museato discussing Vogan’s upcoming absence. She heard him say, “I guess I should not be hiring women into that position or at least not one with a uterus.” (Juenger Dep. at pp. 10-12.) Juenger recalls that Museato made this statement to a group of people at a nurse’s station at Boone Hospital. Juenger has known Museato for six years and she has never before or since heard him make any similar statements.

F. Termination

The Defendants’ leave of absence policy provides that a leave may not exceed ninety days unless additional time for special circumstances was approved by the Regional Vice President. (Def. Ex. 'E at p. 5.) Vogan states that she did not know of the ninety day limit on her leave when she first began her leave. (Vogan Dep. at p. 68.)

On April 2, 2001, Davis wrote Vogan a letter stating that her leave of absence would run through April 80, 2001, and that she would be expected to return to work by that day. This was the first time Vo-gan learned of the ninety day restriction on her leave. In this letter, Davis informed Vogan that she should and could reapply for employment if she were terminated and later wanted to return to work. (Def.Ex. K.) The letter did not mention the special circumstances provision. (Def.Ex. K.)

Vogan did not return to work on or before April 30, 2001.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Self v. Midwest Orthopedics Foot & Ankle, P.C.
272 S.W.3d 364 (Missouri Court of Appeals, 2008)
Levias v. Texas Dept. of Criminal Justice
352 F. Supp. 2d 751 (S.D. Texas, 2004)

Cite This Page — Counsel Stack

Bluebook (online)
301 F. Supp. 2d 1038, 2003 U.S. Dist. LEXIS 25052, 2003 WL 23200384, Counsel Stack Legal Research, https://law.counselstack.com/opinion/vogan-v-us-oncology-inc-mowd-2003.